文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

Billroth II 解剖患者 ERCP 取胆总管结石的预测因素

Predictive factors for extraction of common bile duct stones during endoscopic retrograde cholangiopancreatography in Billroth II anatomy patients.
PubMed 文献 · Surg Endosc · 2019-08-02

该回顾性研究纳入 1999 年 8 月至 2017 年 12 月共 227 例 Billroth II 胃切除术后胆总管结石患者,评估 ERCP 取石结局及影响因素。176 例(77.5%)技术成功,最终 137 例(77.8%)结石取出,多因素分析显示结石数量≥2 和最大结石≥12 mm 是失败危险因素,EPBD/EPLBD 是成功保护因素。

要点

  • Billroth II 解剖患者 ERCP 取胆总管结石技术成功率为 77.5%。
  • 结石数量≥2 和最大结石≥12 mm 是取石失败的独立危险因素。
  • 使用 EPBD/EPLBD 是成功取石的独立保护因素。

核心结论

  • ERCP 对 Billroth II 解剖患者取胆总管结石安全有效。
  • 结石数量、最大结石尺寸及 EPBD/EPLBD 使用是取石预测因素。

研究设计与样本

  • 回顾性分析 1999 年 8 月至 2017 年 12 月单中心 Billroth II 胃切除术后胆总管结石行治疗性 ERCP 取石的患者。
  • 共纳入 227 例患者,分析 ERCP 结局及影响取石的潜在因素。

主要发现

  • 176 例(77.5%)获得技术成功。
  • 十二指肠乳头插管成功率为 84.1%(191/227),选择性胆管插管成功率为 92.1%(176/191)。
  • 胆总管平均直径 15 mm(范围 6-35 mm),最大结石尺寸 13 mm(范围 4-36 mm)。
  • 最终 137 例(77.8%)取出结石,其中 105 例(59.7%)首次取石成功。
  • 机械碎石使用于 17 例(9.7%);ERCP 相关总体并发症率 6.3%(11/176),包括出血 3 例(1.7%)和轻度胰腺炎 6 例(3.4%)。

关键数值与推荐

  • 多因素分析:结石数量≥2(OR 2.171;95% CI 1.095-4.306;p=0.027)是取石失败的患者相关危险因素。
  • 多因素分析:最大结石尺寸≥12 mm(OR 3.646;95% CI 1.833-7.251;p<0.001)是取石失败的患者相关危险因素。
  • 多因素分析:使用 EPBD/EPLBD(OR 0.291;95% CI 0.147-0.576;p<0.001)是成功取石的操作相关保护因素。

临床怎么用

  • 对 Billroth II 解剖患者行 ERCP 取胆总管结石时,应评估结石数量及最大尺寸以预判难度。
  • 可考虑使用 EPBD/EPLBD 以提高取石成功率。

局限性

  • 回顾性单中心研究,结果需外推验证。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) for extraction of common bile duct (CBD) stones in Billroth II anatomy patients is still a technical challenge and factors affecting stone extraction have not yet been clarified. This study aimed to analyze our experience and evaluate potential factors affecting CBD stone extraction. METHODS: A retrospective analysis of CBD stones patients with a history of Billroth II gastrectomy, who underwent therapeutic ERCP for stone extraction at our center from August 1999 to December 2017, was conducted. The outcomes of ERCP and potential factors affecting stone extraction were examined. RESULTS: A total of 227 patients were enrolled, and 176 patients (77.5%) achieved technical success. The success rate of duodenal ampullary access and selective biliary cannulation was 84.1% (191/227) and 92.1% (176/191), respectively. The mean CBD diameter was 15 mm (range 6-35 mm), and the largest stone size was 13 mm (range 4-36 mm). CBD stones were ultimately removed in 137 patients (77.8%), and 105 patients (59.7%) for the first session. Mechanical lithotripsy was used in 17 patients (9.7%). The overall ERCP-related complication rate was 6.3% (11/176), including bleeding in 3 patients (1.7%) and mild pancreatitis in 6 patients (3.4%). The multivariate analysis indicated that CBD stone number ≥ 2 (OR 2.171; 95% CI 1.095-4.306; p = 0.027), and the largest CBD stone size ≥ 12 mm (OR 3.646; 95% CI 1.833-7.251; p < 0.001) were patient-related risk factors for failed stone removal; while the use of endoscopic papillary (large) balloon dilation (EPBD/EPLBD) (OR 0.291; 95% CI 0.147-0.576; p < 0.001) was a procedure-related protective factor for successful stone extraction. CONCLUSIONS: ERCP is safe and effective for extraction of CBD stones in Billroth II anatomy patients. The number and the largest size of CBD stones, and the use of EPBD/EPLBD are predictive factors for CBD stone extraction.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Li JS, Zou DW, Jin ZD, et al. Predictive factors for extraction of common bile duct stones during endoscopic retrograde cholangiopancreatography in Billroth II anatomy patients. Surg Endosc. 2019. PMID: 31376008. doi:10.1007/s00464-019-07039-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。